CN104840474A - Preparation method of externally applied liquid medicine for treating foot corns, callus and verruca plantaris - Google Patents
Preparation method of externally applied liquid medicine for treating foot corns, callus and verruca plantaris Download PDFInfo
- Publication number
- CN104840474A CN104840474A CN201510195371.4A CN201510195371A CN104840474A CN 104840474 A CN104840474 A CN 104840474A CN 201510195371 A CN201510195371 A CN 201510195371A CN 104840474 A CN104840474 A CN 104840474A
- Authority
- CN
- China
- Prior art keywords
- salicylic acid
- dimethyl sulfoxide
- preparation
- callus
- sulfoxide solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a preparation method of an externally applied liquid medicine for treating foot corns, callus and verruca plantaris. The preparation method comprises adding salicylic acid into a dimethyl sulfoxide solvent, carrying out mixing to obtain a uniform salicylic acid-dimethyl sulfoxide solution, wherein a volume ratio of the used salicylic acid to the dimethyl sulfoxide solvent is 9-11% and preferably, a volume ratio of the used salicylic acid to the dimethyl sulfoxide solvent is 10%, carrying out split-charging on the salicylic acid-dimethyl sulfoxide solution by brown shading bottles, and carrying out seal storage under the conditions of no high temperature and no low temperature. The externally applied liquid medicine has the advantages of simple preparation method, low cost, cheap price, good safety, no pain, use convenience and difficult recurrence, and has the corn and callus clinical treatment effective rate of about 95-99% and the verruca plantaris clinical treatment effective rate of about 83-92%.
Description
Technical field
The present invention relates to drug world, specifically treat the preparation method of the lotion of foot helosis, callus and plantar wart disease.
Background technology
Human foot clavus, callus and plantar wart disease are common dermatosis, sickness rate is high, the particularly women at various age, they are because the various unsuitable footwear boots of dress are (as high-heel shoes, pointed shoes, walking shoes) reason, the sickness rate of foot helosis, the callus ordinary people that compares is higher, in addition, because leather boots will be worn for a long time or liberates footwear carry out on duty and training mission, foot helosis in many grassroots army unit officers and men, the sickness rate of callus is also very high, but the many Therapeutic Method carried out clinically are at present as excision, laser therapy, micro-wave therapeutic, there is many shortcomings in corn plaster etc.: the course for the treatment of had is long, some therapeutic processes are more painful, some expenses are higher, and easily recurrence after a lot of method treatment, not easily effect a radical cure, very large impact is all brought to minimal invasive treatment and work, many patients suffer from can not find a kind of simple effectively, Therapeutic Method with low cost, helplessly can only accept above-mentioned traditional therapy for a long time.
Summary of the invention
The object of the present invention is to provide the preparation method of the lotion for the treatment of foot helosis, callus and the plantar wart disease that cost is low, safety good, not easily recur, to solve the problem proposed in above-mentioned background technology.
For achieving the above object, the invention provides following technical scheme:
The preparation method of the lotion for the treatment of foot helosis, callus and plantar wart disease, salicylic acid is added in dimethyl sulfoxide solvent, mix homogeneously obtains salicylic acid dimethyl sulphoxide solution, wherein according to percent by volume, salicylic addition is the 9-11% of dimethyl sulfoxide solvent volume, salicylic acid dimethyl sulphoxide solution is divided in brown lucifuge vial, holding conditions: sealing is preserved, and reserve temperature is not less than 4 DEG C and is no more than 40 DEG C.
As the further scheme of the present invention: according to percent by volume, salicylic addition is 10% of dimethyl sulfoxide solvent volume.
Compared with prior art, the invention has the beneficial effects as follows: process for preparing medicine of the present invention is simple, with low cost, low price, and safety is good, and no pain is easy to use, not easily recurs; And after clinic trial, 95%-99% being about for the effective percentage of clavus, callus, the effective percentage of plantar wart disease is about 83%-92%.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, the preparation method of the lotion for the treatment of foot helosis, callus and plantar wart disease, salicylic acid is added in dimethyl sulfoxide solvent, mix homogeneously obtains salicylic acid dimethyl sulphoxide solution, wherein according to percent by volume, salicylic addition is 9% of dimethyl sulfoxide solvent volume, salicylic acid dimethyl sulphoxide solution is divided in the brown lucifuge vial of 10ml capacity, holding conditions: sealing is preserved, avoid high temperature and low temperature, high temperature is no more than 40 DEG C, and low temperature is not less than 4 DEG C.
Embodiment 2
In the embodiment of the present invention, the preparation method of the lotion for the treatment of foot helosis, callus and plantar wart disease, salicylic acid is added in dimethyl sulfoxide solvent, mix homogeneously obtains salicylic acid dimethyl sulphoxide solution, wherein according to percent by volume, salicylic addition is 10% of dimethyl sulfoxide solvent volume, salicylic acid dimethyl sulphoxide solution is divided in the brown lucifuge vial of 10ml capacity, holding conditions: sealing is preserved, avoid high temperature and low temperature, high temperature is no more than 40 DEG C, and low temperature is not less than 4 DEG C.The embodiment of the present invention is preferred version.
Embodiment 3
In the embodiment of the present invention, the preparation method of the lotion for the treatment of foot helosis, callus and plantar wart disease, salicylic acid is added in dimethyl sulfoxide solvent, mix homogeneously obtains salicylic acid dimethyl sulphoxide solution, wherein according to percent by volume, salicylic addition is 11% of dimethyl sulfoxide solvent volume, salicylic acid dimethyl sulphoxide solution is divided in the brown lucifuge vial of 10ml capacity, holding conditions: sealing is preserved, avoid high temperature and low temperature, high temperature is no more than 40 DEG C, and low temperature is not less than 4 DEG C.
The medicine toothpick of above-mentioned preparation in use, is first dipped a small amount of medicinal liquid by after foot cleaning, drying at every turn, is carefully applied to pathological changes neighboring by the present invention, need after medicinal liquid drying, every day 1-2 time, and after using 5-7 days continuously, sick body can come off gradually.After sick body comes off, wound surface every day dips in upper a little povidone iodine medicinal liquid with cotton swab and is coated in wound site sterilization prevention infection, and within 3-5 days, wound surface can heal.Medicinal liquid should be avoided during use as far as possible to contact normal skin tissue, or contact other article such as footgear when the non-bone dry of foot medicinal liquid.As long as remainder does not use medicinal liquid and preserves as requested, still can continue before the deadline to use.
The present invention is with low cost, low price, and safety is good, easy to use, and user oneself just can independently treat at home, and no pain, not easily recurs, and from clinical practice situation, actual efficacy is obvious.Preparation equipment of the present invention requires very low, and after extensive preparation forms preparation, can be supplied to the uses such as hospital, community medical institutions, pharmacy, army, clinic from far-off regions, wide market, because with low cost, expection economic benefit is obvious.But exactly because Formulation Ingredients is simple involved by patent of the present invention, easy to use, with low cost, good effect, so in expected future, the present invention is once make products in circulation use, very easily imitated, or on formula basis involved in the present invention, add some composition carry out what is called " improvement " or " improvement ", and abuse not easily judges, therefore the required content of protection and the scope of authorizing of patent of the present invention not only comprises concentration range involved by formula, mainly emphasize its Formulation Ingredients related to, as long as contained composition relates to this patent and all should be considered and invade the right of this patent in similar products, infringement should be judged to be, protected by law, and take relevant law measure.To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.
In addition, be to be understood that, although this description is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of description is only for clarity sake, those skilled in the art should by description integrally, and the technical scheme in each embodiment also through appropriately combined, can form other embodiments that it will be appreciated by those skilled in the art that.
Claims (2)
1. treat the preparation method of the lotion of foot helosis, callus and plantar wart disease, it is characterized in that, salicylic acid is added in dimethyl sulfoxide solvent, mix homogeneously obtains salicylic acid dimethyl sulphoxide solution, wherein according to percent by volume, salicylic addition is the 9-11% of dimethyl sulfoxide solvent volume, is divided in by salicylic acid dimethyl sulphoxide solution in brown lucifuge vial, holding conditions: sealing is preserved, and reserve temperature is not less than 4 DEG C and is no more than 40 DEG C.
2. the preparation method of the lotion for the treatment of foot helosis according to claim 1, callus and plantar wart disease, is characterized in that, according to percent by volume, salicylic addition is 10% of dimethyl sulfoxide solvent volume.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510195371.4A CN104840474A (en) | 2015-04-23 | 2015-04-23 | Preparation method of externally applied liquid medicine for treating foot corns, callus and verruca plantaris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510195371.4A CN104840474A (en) | 2015-04-23 | 2015-04-23 | Preparation method of externally applied liquid medicine for treating foot corns, callus and verruca plantaris |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104840474A true CN104840474A (en) | 2015-08-19 |
Family
ID=53840723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510195371.4A Pending CN104840474A (en) | 2015-04-23 | 2015-04-23 | Preparation method of externally applied liquid medicine for treating foot corns, callus and verruca plantaris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104840474A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106492203A (en) * | 2016-12-07 | 2017-03-15 | 郑州仁宏医药科技有限公司 | A kind of Western medicine combination paste of thorough radical cure corn and preparation method thereof |
| CN106692265A (en) * | 2017-03-03 | 2017-05-24 | 潘鑫 | Externally-used medicine for treating plantar verruca |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161837A (en) * | 1996-04-11 | 1997-10-15 | 白奇林 | Medicine for treating tinea pedis |
| CN102379839A (en) * | 2010-08-30 | 2012-03-21 | 殷峰林 | Preparation method of salicylic acid ointment |
-
2015
- 2015-04-23 CN CN201510195371.4A patent/CN104840474A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161837A (en) * | 1996-04-11 | 1997-10-15 | 白奇林 | Medicine for treating tinea pedis |
| CN102379839A (en) * | 2010-08-30 | 2012-03-21 | 殷峰林 | Preparation method of salicylic acid ointment |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106492203A (en) * | 2016-12-07 | 2017-03-15 | 郑州仁宏医药科技有限公司 | A kind of Western medicine combination paste of thorough radical cure corn and preparation method thereof |
| CN106692265A (en) * | 2017-03-03 | 2017-05-24 | 潘鑫 | Externally-used medicine for treating plantar verruca |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105142728B (en) | Compositions and methods for treating surface wounds | |
| Bloomgarden | American diabetes association 60th scientific sessions, 2000: the diabetic foot | |
| JPH0617299B2 (en) | Povidone-pharmaceutical composition containing iodine and sugar | |
| JP2012501348A (en) | Homeopathic treatment | |
| López-López et al. | Application of cantharidin, podophyllotoxin, and salicylic acid in recalcitrant plantar warts. A preliminary study | |
| Hayashida et al. | Effectiveness of basic fibroblast growth factor for pediatric hand burns | |
| Armstrong et al. | Offloading foot wounds in people with diabetes | |
| Ng et al. | Topical use of antithrombotics: review of literature | |
| CN104840474A (en) | Preparation method of externally applied liquid medicine for treating foot corns, callus and verruca plantaris | |
| CA3092373C (en) | Topical wound care formulation | |
| RU2423118C1 (en) | Method of treating trophic ulcers | |
| Brown et al. | Randomized standard-of-care-controlled trial of a silica gel fibre matrix in the treatment of chronic venous leg ulcers | |
| CN103768388A (en) | Traditional Chinese medicine formula for treating scalds, burns and trauma by being singly applied externally | |
| WO2009027823A2 (en) | Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. | |
| Triana-Ricci et al. | Management recommendations for diabetic foot patients. Instructional course | |
| KR101607229B1 (en) | A composition for treating wound containing horse oil | |
| US20210038669A1 (en) | Composition(s) for Topically Treating Pain | |
| RU2268739C2 (en) | Therapeutic gel based on bioactive blood-sucker producing substances and method for production thereof | |
| RU2209616C2 (en) | Method for increasing efficiency of hyperbaric oxygenation (hbo) | |
| WO2020144565A1 (en) | Composition for use in the treatment of skin lesions in cancer patients | |
| Hussain et al. | Nongenital warts: recommended management in general practice | |
| Rehbock | Common skin conditions that are treated by the podiatrist: clinical | |
| CN114712373A (en) | Skin antibacterial agent and preparation method thereof | |
| CN109954127A (en) | A kind of placental peptide injection | |
| CN104800265A (en) | Ointment for treating diabetic foot |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150819 |
|
| RJ01 | Rejection of invention patent application after publication |